About Tasly

Tasly was founded on May 1994. Through decades of development with Great Health industry as guideline and pharmaceutical industry as its center, Tasly has become a hi-tech group whose scope of business includes modern TCM, chemical medicine, biological medicine, healthcare products, functional food, covering the fields of research and development, planting, manufacturing and distribution.

Tasly, through innovations in standards and technologies, has created a manufacturing process for TCM modernization and set up an internationalized advanced, standardized, digital and intelligent big industrial system which produces high-quality, stable and controllable TCM products. Utilizing ground-breaking technology and cutting-edge science, Tasly has performed over 1000 clinical research trials and it has developed chemical-free medications which have been approved by FDA, the medicine have been lauched in 34 countries benefiting over a billion patients worldwide.

Tasly was successfully listed as public company (Class A stock ) in Shanghai Stock Exchange on August 8th, 2002, which symbolizes the start of capital operation of Tasly. This spurs on Tasly to make large dose determination in accelerating its progress in all aspects.

 

Tasly Health Products

In recent years, Tasly’s strategy of internationalization is being conducted in full swing. Tasly had already set up two organizing systems of international trade and international direct sales, and established a global marketing mode of expanding from developing countries to developed countries, and taking direct sales as major force to bring along distribution method. Key regional markets have taken shape in Southeast Asia, Europe, North America and Africa. Its major products have registered in 34 countries and regions, and Cardiotonic Pill undergoes FDA and EMEA Phase II and Phase III clinical trials.

By the end of 2006,only in Africa, the number of members reaches 220,000, covering 20 countries. The overseas branches earned $31.58 million in sales, and $6.97 million foreign exchange through self-run export. Local influence of the brand effect has taken shape. Channels for overseas cooperation keep expanding, and this lays solid foundation for TCM entering into the main stream of international medical market.

Tasly Holding Group Incorporated in 1994 with registered capital of CNY240 million, Tasly Holding Group currently has 50-odd branches and subsidiaries and 15,000 employees. The hi-tech transnational conglomerate, which devotes itself to the Pan-health industry with biopharmaceuticals as its trunk and with the health industry like health products and functional foods and health management and service as its wings, has established industrial facilities in Tianjin, Jiangsu, Yunnan, Guizhou and Hunan.

Open chat
Scan the code
We are Only About Tasly Health Products

How can we assist you order online today? We offer Simple Payment Options.